Content provided in partnership with
Technology Industry
Industry: Email Alert RSS FeedVenture capital watch
BT Catalyst, Sept-Oct, 2004
Four venture capital deals worth $30 million were announced in June, July and August by North Carolina biotechnology companies.
Affinergy, Research Triangle Park, $2 million Investors: MCNC; Trinity Healthcare; Charleston Angel Partners; Wilmington Investor Network; numerous individuals.
Alveolus, Charlotte, $10 million Investors: MDS Capital; FCA Venture Partners III; MB Venture Partners; Healthcare Capital Partners; Matignon Technologies.
Serenex, Durham, $8 million Investors: Intersouth Partners; Takeda Research Investment; Western Technology Investment; Mediphase Venture Partners, Lilly BioVentures; Seaflower Ventures.
- Most Popular Articles in Technology
- An overview of continuous data protection
- Why all those current ratings?
- Many countries now have a mobile penetration rate above 100%, report says
- The Tata Group's big telecom gamble: VSNL's recent acquisition of Tyco ...
- MEASURING BANK BRANCH EFFICIENCY USING DATA ENVELOPMENT ANALYSIS: MANAGERIAL ...
- More »
TransTech Pharma, High Point, $10 million Investors: MacAndrews & Forbes Holdings; Novo.
COPYRIGHT 2004 North Carolina Biotechnology Center
COPYRIGHT 2008 Gale, Cengage Learning
Find Research Guides for:
Find Featured Titles for: News
Most Popular Articles in Technology
- An overview of continuous data protection
- Why all those current ratings?
- Many countries now have a mobile penetration rate above 100%, report says
- The Tata Group's big telecom gamble: VSNL's recent acquisition of Tyco ...
- MEASURING BANK BRANCH EFFICIENCY USING DATA ENVELOPMENT ANALYSIS: MANAGERIAL ...
- More »